Phase III IGRT and SBRT Vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
GU005 is closed to accrual effective June 8, 2022 at 5pm ET.
Because the AJCC staging version 8 was not ready for the study activation, AJCC staging version 7 must be used.
